Ind-Swift Laboratories (NSE:INDSWFTLAB) YoY EBITDA Growth : -5.16% (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Ind-Swift Laboratories YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Ind-Swift Laboratories's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -5.16%.

Ind-Swift Laboratories's EBITDA per Share for the three months ended in Dec. 2023 was ₹9.96.

Ind-Swift Laboratories YoY EBITDA Growth Historical Data

The historical data trend for Ind-Swift Laboratories's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ind-Swift Laboratories YoY EBITDA Growth Chart

Ind-Swift Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

YoY EBITDA Growth

Get a 7-Day Free Trial

31.11

-32.79

15.00

18.31

-1.48

Ind-Swift Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															2.20	-21.30	9.34	10.26	-5.16

Ind-Swift Laboratories YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Ind-Swift Laboratories's YoY EBITDA Growth for the fiscal year that ended in Mar. 2023 is calculated as:

	YoY EBITDA Growth (A: Mar. 2023 )
=	(EBITDA per Share (A: Mar. 2023 )	-	EBITDA per Share (A: Mar. 2022 ))	/	\| EBITDA per Share (A: Mar. 2022 ) \|
=	(39.189	-	39.776)	/	\| 39.776 \|
=	-1.48 %

Ind-Swift Laboratories's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(9.963	-	10.505)	/	\| 10.505 \|
=	-5.16 %

Ind-Swift Laboratories YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Ind-Swift Laboratories's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Ind-Swift Laboratories (NSE:INDSWFTLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ind-Swift Laboratories Ltd (NSE:INDSWFTLAB) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

532305:India

Address

SCO 850, Shivalik Enclave, NAC, Manimajra, Chandigarh, PB, IND, 160 101

Website

https://www.indswiftlabs.com

Ind-Swift Laboratories Ltd is engaged in the business of active pharmaceutical ingredients (API). The company caters to diverse therapeutic segments namely Cardiovascular health, Antihistamine, Antidiabetic, Antipsychotic, Parkinson's Disease, Antineoplastic, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitor. Geographically, it derives a majority of revenue from Outside India.

Ind-Swift Laboratories (NSE:INDSWFTLAB) Headlines

No Headlines